Swiss drugs regulator approves first bivalent COVID-19 booster
A test tube labelled “COVID-19 Test Positive” and a vial labelled “VACCINE Coronavirus COVID-19” are seen in this illustration taken December 11, 2021. REUTERS
BERLIN — Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent Covid-19 booster vaccine in the country.
Moderna’s Spikevax vaccine, which contains mRNA against two coronavirus variants, is authorized for anyone 18 years or older, said Swissmedic.
Article continues after this advertisement
RELATED STORIES
FEATURED STORIES
DOH open to new jabs, but sees no need yet
UK clears new Moderna vaccine targeting Omicron variant
Article continues after this advertisementPfizer seeks US authorization for vaccine booster retooled for Omicron
UK first to approve Omicron COVID-19 shot with Moderna nod
Your subscription could not be saved. Please try again.
Your subscription has been successful.
READ NEXT
EDITORS' PICK
